{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:27:02Z","timestamp":1760747222473,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/R513143\/1"],"award-info":[{"award-number":["EP\/R513143\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Bayesian cost-effectiveness analysis (CEA) requires the specification of prior distributions for all parameters to be empirically estimated via Bayes\u2019 rule. When costs are modelled via Log-Normal distributions, Uniform prior distributions are commonly applied on the logarithm-scale standard deviations for costs due to the ease of implementation. However, the consequences of placing wide Uniform priors on standard deviations of log costs for the interpretation of original-scale CEA results remain unclear. The purpose of our study is to explore the impact of using Uniform priors for the standard deviations of cost data on CEA conclusions when costs are assumed to be log-normally distributed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The analysis has been performed using individual-level cost-utility data from a randomised controlled trial. Costs are initially jointly modelled with quality-adjusted life years (QALYs) using Log-Normal and Beta distributions, respectively. Uniform prior distributions with different upper bounds are applied to log-scale standard deviations in the cost Log-Normal model. We compare the performance of Uniform priors under the Log-Normal distribution with other distributional assumptions for costs. A simulation study has then been conducted to explore the impact of these models and prior choices on cost estimates in CEAs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Results show that the choice of Uniform priors on standard deviations of log costs in a Log-Normal model can substantially induce large fluctuations in cost estimates, and thus potentially affect the final estimates of the intervention being cost-effective compared with other distributional assumptions. This is potentially driven by the occurrence of zero values in cost data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Bayesian CEAs may be sensitive to the choice of upper bounds of the Uniform priors for the standard deviations of log costs in Log-Normal models, particularly when data contain zero values. Our results suggest that caution should be taken when Uniform distributions with large upper bounds are used.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40273-025-01511-1","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T13:56:53Z","timestamp":1755007013000},"page":"1309-1321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bayesian Cost-Effectiveness Analysis Using Individual-Level Data is Sensitive to the Choice of Uniform Priors on the Standard Deviations for Costs in Log-Normal Models"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-7417","authenticated-orcid":false,"given":"Xiaoxiao","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7650-4534","authenticated-orcid":false,"given":"Andrea","family":"Gabrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-2570","authenticated-orcid":false,"given":"Gianluca","family":"Baio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1017\/S0266462301104071","volume":"17","author":"A Briggs","year":"2001","unstructured":"Briggs A. A Bayesian approach to stochastic cost-effectiveness analysis: an illustration and application to blood pressure control in type 2 diabetes. Int J Technol Assess Health Care. 2001;17:69\u201382. https:\/\/doi.org\/10.1017\/S0266462301104071.","journal-title":"Int J Technol Assess Health Care"},{"key":"1511_CR2","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1002\/sim.1586","volume":"22","author":"D Spiegelhalter","year":"2003","unstructured":"Spiegelhalter D, Best N. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med. 2003;22:3687\u2013709. https:\/\/doi.org\/10.1002\/sim.1586.","journal-title":"Stat Med"},{"key":"1511_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1191\/0962280202sm305ra","volume":"11","author":"A O\u2019Hagan","year":"2002","unstructured":"O\u2019Hagan A, Stevens J. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Stat Methods Med Res. 2002;11:469\u201390. https:\/\/doi.org\/10.1191\/0962280202sm305ra.","journal-title":"Stat Methods Med Res"},{"key":"1511_CR4","volume-title":"Bayesian statistical economic evaluation methods for health technology assessment. Oxf. Res. Encycl. Econ. Finance","author":"A Gabrio","year":"2019","unstructured":"Gabrio A, Baio G, Manca A. Bayesian statistical economic evaluation methods for health technology assessment. Oxf. Res. Encycl. Econ. Finance. Oxford: Oxford University Press; 2019."},{"key":"1511_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/hec.617","volume":"10","author":"A O\u2019Hagan","year":"2001","unstructured":"O\u2019Hagan A, Stevens J. A framework for cost-effectiveness analysis from clinical trial data. Health Econ. 2001;10:303\u201315. https:\/\/doi.org\/10.1002\/hec.617.","journal-title":"Health Econ"},{"key":"1511_CR6","doi-asserted-by":"publisher","DOI":"10.1201\/b13099","volume-title":"Bayesian methods in health economics","author":"G Baio","year":"2012","unstructured":"Baio G. Bayesian methods in health economics. Boca Raton: CRC Press; 2012."},{"key":"1511_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1017\/S0266462309990316","volume":"25","author":"CE McCarron","year":"2009","unstructured":"McCarron CE, Pullenayegum E, Marshall D, Goeree R, Tarride J-E. Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments. Int J Technol Assess Health Care. 2009;25:546\u201354. https:\/\/doi.org\/10.1017\/S0266462309990316.","journal-title":"Int J Technol Assess Health Care"},{"key":"1511_CR8","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/sim.6074","volume":"33","author":"G Baio","year":"2014","unstructured":"Baio G. Bayesian models for cost-effectiveness analysis in the presence of structural zero costs. Stat Med. 2014;33:1900\u201313. https:\/\/doi.org\/10.1002\/sim.6074.","journal-title":"Stat Med"},{"key":"1511_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/0272989X07302132","volume":"27","author":"A Manca","year":"2007","unstructured":"Manca A, Lambert P, Sculpher M, Rice N. Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling. Med Decis Mak. 2007;27:471\u201390. https:\/\/doi.org\/10.1177\/0272989X07302132.","journal-title":"Med Decis Mak"},{"key":"1511_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0272989X12458457","volume":"33","author":"CE McCarron","year":"2013","unstructured":"McCarron CE, Pullenayegum E, Thabane L, Goeree R, Tarride J-E. The impact of using informative priors in a bayesian cost-effectiveness analysis: an application of endovascular versus open surgical repair for abdominal aortic aneurysms in high-risk patients. Med Decis Mak. 2013;33:437\u201350. https:\/\/doi.org\/10.1177\/0272989X12458457.","journal-title":"Med Decis Mak"},{"key":"1511_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0272989X09341752","volume":"30","author":"R Grieve","year":"2010","unstructured":"Grieve R, Nixon R, Thompson S. Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials. Med Decis Mak. 2010;30:163\u201375. https:\/\/doi.org\/10.1177\/0272989X09341752.","journal-title":"Med Decis Mak"},{"key":"1511_CR12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/sim.8045","volume":"38","author":"A Gabrio","year":"2019","unstructured":"Gabrio A, Mason A, Baio G. A full Bayesian model to handle structural ones and missingness in economic evaluations from individual-level data: handling structural ones and missingness in economic evaluations. Stat Med. 2019;38:1399\u2013420. https:\/\/doi.org\/10.1002\/sim.8045.","journal-title":"Stat Med"},{"key":"1511_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/rssa.12522","volume":"183","author":"A Gabrio","year":"2020","unstructured":"Gabrio A, Daniels M, Baio G. A Bayesian parametric approach to handle missing longitudinal outcome data in trial-based health economic evaluations. J R Stat Soc Ser A Stat Soc. 2020;183:607\u201329. https:\/\/doi.org\/10.1111\/rssa.12522.","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"1511_CR14","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/sim.2112","volume":"24","author":"P Lambert","year":"2005","unstructured":"Lambert P, Sutton A, Burton P, Abrams K, Jones D. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med. 2005;24:2401\u201328. https:\/\/doi.org\/10.1002\/sim.2112.","journal-title":"Stat Med"},{"key":"1511_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/sjos.12229","volume":"43","author":"E Fabrizi","year":"2016","unstructured":"Fabrizi E, Trivisano C. Bayesian conditional mean estimation in log-normal linear regression models with finite quadratic expected loss. Scand J Stat. 2016;43:1064\u201377. https:\/\/doi.org\/10.1111\/sjos.12229.","journal-title":"Scand J Stat"},{"key":"1511_CR16","doi-asserted-by":"publisher","DOI":"10.1214\/06-BA117A","author":"A Gelman","year":"2006","unstructured":"Gelman A. Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper). Bayesian Anal. 2006. https:\/\/doi.org\/10.1214\/06-BA117A.","journal-title":"Bayesian Anal"},{"key":"1511_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/01621459.1971.10482263","volume":"66","author":"A Zellner","year":"1971","unstructured":"Zellner A. Bayesian and non-Bayesian analysis of the log-normal distribution and log-normal regression. J Am Stat Assoc. 1971;66:327\u201330.","journal-title":"J Am Stat Assoc"},{"key":"1511_CR18","doi-asserted-by":"publisher","DOI":"10.1214\/12-BA733","author":"E Fabrizi","year":"2012","unstructured":"Fabrizi E, Trivisano C. Bayesian estimation of log-normal means with finite quadratic expected loss. Bayesian Anal. 2012. https:\/\/doi.org\/10.1214\/12-BA733.","journal-title":"Bayesian Anal"},{"key":"1511_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S2215-0366(21)00235-2","volume":"8","author":"C Hollis","year":"2021","unstructured":"Hollis C, Hall CL, Jones R, Marston L, Novere ML, Hunter R, et al. Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial. Lancet Psychiatry. 2021;8:871\u201382. https:\/\/doi.org\/10.1016\/S2215-0366(21)00235-2.","journal-title":"Lancet Psychiatry"},{"key":"1511_CR20","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","volume":"12","author":"M Weinstein","year":"2009","unstructured":"Weinstein M, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12:S5-9. https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00515.x.","journal-title":"Value Health"},{"key":"1511_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/0272989X05276862","volume":"25","author":"S Thompson","year":"2005","unstructured":"Thompson S, Nixon R. How sensitive are cost-effectiveness analyses to choice of parametric distributions? Med Decis Mak. 2005;25:416\u201323. https:\/\/doi.org\/10.1177\/0272989X05276862.","journal-title":"Med Decis Mak"},{"key":"1511_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/01621459.1962.10480664","volume":"57","author":"A Zellner","year":"1962","unstructured":"Zellner A. An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias. J Am Stat Assoc. 1962;57:348\u201368.","journal-title":"J Am Stat Assoc"},{"key":"1511_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1258\/1355819042250249","volume":"9","author":"J Barber","year":"2004","unstructured":"Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy. 2004;9:197\u2013204. https:\/\/doi.org\/10.1258\/1355819042250249.","journal-title":"J Health Serv Res Policy"},{"key":"1511_CR24","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/sim.1744","volume":"23","author":"R Nixon","year":"2004","unstructured":"Nixon R, Thompson S. Parametric modelling of cost data in medical studies. Stat Med. 2004;23:1311\u201331. https:\/\/doi.org\/10.1002\/sim.1744.","journal-title":"Stat Med"},{"key":"1511_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/hec.941","volume":"14","author":"A Briggs","year":"2005","unstructured":"Briggs A, Nixon R, Dixon S, Thompson S. Parametric modelling of cost data: some simulation evidence. Health Econ. 2005;14:421\u20138. https:\/\/doi.org\/10.1002\/hec.941.","journal-title":"Health Econ"},{"key":"1511_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0272989X11416988","volume":"32","author":"A Basu","year":"2012","unstructured":"Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Med Decis Mak. 2012;32:56\u201369. https:\/\/doi.org\/10.1177\/0272989X11416988.","journal-title":"Med Decis Mak"},{"key":"1511_CR27","unstructured":"Plummer M. JAGS: a program for analysis of Bayesian graphical models using Gibbs sampling. In: 3rd Int Workshop Distrib Stat Comput DSC 2003 Vienna. p. 124; 2003."},{"key":"1511_CR28","unstructured":"Su YS, Yajima M, Su MY, SystemRequirements JA. Package \u2018r2jags\u2019. R package version 0.03-08; 22 Aug 2015. http:\/\/CRAN.R-project.org\/package=R2jags."},{"key":"1511_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1214\/ss\/1177011136","volume":"7","author":"A Gelman","year":"1992","unstructured":"Gelman A, Rubin D. Inference from iterative simulation using multiple sequences. Stat Sci. 1992;7:457\u201372.","journal-title":"Stat Sci"},{"key":"1511_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-9868.00353","volume":"64","author":"D Spiegelhalter","year":"2002","unstructured":"Spiegelhalter D, Best N, Carlin B, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B Stat Methodol. 2002;64:583\u2013639. https:\/\/doi.org\/10.1111\/1467-9868.00353.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"1511_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/0272989X9001000308","volume":"10","author":"WC Black","year":"1990","unstructured":"Black WC, The CE. Plane: a graphic representation of cost-effectiveness. Med Decis Mak. 1990;10:212\u20134. https:\/\/doi.org\/10.1177\/0272989X9001000308.","journal-title":"Med Decis Mak"},{"key":"1511_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hec.4730030505","volume":"3","author":"BA Van Hout","year":"1994","unstructured":"Van Hout BA, Al MJ, Gordon GS, Rutten FFH. Costs, effects and C\/E-ratios alongside a clinical trial. Health Econ. 1994;3:309\u201319. https:\/\/doi.org\/10.1002\/hec.4730030505.","journal-title":"Health Econ"},{"key":"1511_CR33","volume-title":"Statistical analysis with missing data","author":"R Little","year":"2019","unstructured":"Little R, Rubin D. Statistical analysis with missing data, vol. 793. New Jersey: John Wiley & Sons; 2019."},{"key":"1511_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/obes.12583","volume":"86","author":"J Mullahy","year":"2024","unstructured":"Mullahy J, Norton EC. Why transform Y\u202f? The pitfalls of transformed regressions with a mass at zero. Oxf Bull Econ Stat. 2024;86:417\u201347. https:\/\/doi.org\/10.1111\/obes.12583.","journal-title":"Oxf Bull Econ Stat"},{"key":"1511_CR35","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1002\/sim.7050","volume":"35","author":"B Neelon","year":"2016","unstructured":"Neelon B, O\u2019Malley AJ, Smith VA. Modeling zero-modified count and semicontinuous data in health services research. Part 1: background and overview. Stat Med. 2016;35:5070\u201393. https:\/\/doi.org\/10.1002\/sim.7050.","journal-title":"Stat Med"},{"key":"1511_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hec.1141","volume":"16","author":"NJ Cooper","year":"2007","unstructured":"Cooper NJ, Lambert PC, Abrams KR, Sutton AJ. Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis. Health Econ. 2007;16:37\u201356. https:\/\/doi.org\/10.1002\/hec.1141.","journal-title":"Health Econ"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-025-01511-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-025-01511-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-025-01511-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:41:49Z","timestamp":1760715709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-025-01511-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s40273-025-01511-1","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"type":"print","value":"1170-7690"},{"type":"electronic","value":"1179-2027"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"18 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Engineering and Physical Sciences Research Council, EP\/R513143\/1, Xiaoxiao Ling.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"XL was funded for her PhD study at University College London, UK, by the Engineering and Physical Science Research Council (EPSRC), UK (Grant EP\/R513143\/1) at the time this work was carried out. The funder had no role in the study and its submission. XL, AG and GB declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The ORBIT trial data that support the findings of this article are not openly available from the authors due to a data access agreement with the original trial team. For access to the data, please contact the ORBIT trial team directly.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}